|
US5814651A
(en)
|
1992-12-02 |
1998-09-29 |
Pfizer Inc. |
Catechol diethers as selective PDEIV inhibitors
|
|
WO1994017197A1
(fr)
|
1993-01-25 |
1994-08-04 |
Takeda Chemical Industries, Ltd. |
ANTICORPS DIRIGE CONTRE LE β-AMYLOIDE OU UN DERIVE DE CE DERNIER ET SON UTILISATION
|
|
JPH08295667A
(ja)
*
|
1995-04-27 |
1996-11-12 |
Takeda Chem Ind Ltd |
複素環化合物、その製造法および剤
|
|
JPH08295687A
(ja)
*
|
1995-04-28 |
1996-11-12 |
Ube Ind Ltd |
無水シトラコン酸の製造法
|
|
DE19709877A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
|
|
CN1177616C
(zh)
|
1997-04-09 |
2004-12-01 |
曼德塞特生物制药公司 |
特异于β-淀粉状蛋白末端的重组抗体,编码它们的DNA及其使用方法
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
BR9916746A
(pt)
*
|
1999-06-03 |
2005-01-11 |
Abbott Lab |
Compostos anti-inflamatórios que inibem adesão de célula
|
|
CA2376781A1
(en)
|
1999-06-28 |
2001-01-04 |
Janssen Pharmaceutica N.V. |
Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
|
|
US20030187261A1
(en)
|
2000-01-07 |
2003-10-02 |
Libor Havlicek |
Purine derivatives, process for their preparation and use thereof
|
|
WO2001062801A2
(en)
|
2000-02-24 |
2001-08-30 |
Washington University |
Humanized antibodies that sequester amyloid beta peptide
|
|
JP3729343B2
(ja)
|
2000-04-27 |
2005-12-21 |
アステラス製薬株式会社 |
縮合ヘテロアリール誘導体
|
|
DE10045112A1
(de)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
|
|
AU3976402A
(en)
|
2000-11-03 |
2002-06-03 |
Proteotech Inc |
Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
|
|
GB0115181D0
(en)
|
2001-06-20 |
2001-08-15 |
Glaxo Group Ltd |
Novel use
|
|
WO2003000697A1
(en)
|
2001-06-22 |
2003-01-03 |
Takeda Chemical Industries, Ltd. |
Furoisoquinoline derivative, process for producing the same, and use
|
|
EP1404330B1
(en)
|
2001-06-27 |
2005-06-01 |
Merck Frosst Canada & Co. |
Substituted 8-arylquinoline pde4 inhibitors
|
|
EP1405844A4
(en)
|
2001-06-29 |
2006-09-20 |
Nikken Chemicals Co Ltd |
CYCLOALKENONDERIVAT
|
|
WO2003008396A1
(en)
|
2001-07-16 |
2003-01-30 |
Nikken Chemicals Co., Ltd. |
Optically active oxazine derivative
|
|
AU2002354850B2
(en)
|
2001-07-18 |
2008-02-28 |
Merck Patent Gmbh |
4-(benzylidene-amino)-3-(methylsulfanyl)-4H-(1, 2, 4) triazin-5-one derivatives having a PDE-IV inhibiting and TNF-antagonistic effect for the treatment of cardiac diseases and allergies
|
|
WO2003008373A1
(de)
|
2001-07-19 |
2003-01-30 |
Merck Patent Gmbh |
Tyrosinhydrazide
|
|
FR2827599A1
(fr)
|
2001-07-20 |
2003-01-24 |
Neuro3D |
Composes derives de quinoleine et quinoxaline,preparation et utilisations
|
|
GB0118373D0
(en)
|
2001-07-27 |
2001-09-19 |
Glaxo Group Ltd |
Novel therapeutic method
|
|
TWI221838B
(en)
|
2001-08-09 |
2004-10-11 |
Tanabe Seiyaku Co |
Pyrazinoisoquinoline compound or naphthalene compound
|
|
EP1285922A1
(en)
|
2001-08-13 |
2003-02-26 |
Warner-Lambert Company |
1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
|
|
FR2828693B1
(fr)
|
2001-08-14 |
2004-06-18 |
Exonhit Therapeutics Sa |
Nouvelle cible moleculaire de la neurotoxicite
|
|
CA2456985A1
(en)
|
2001-08-15 |
2003-02-27 |
Icos Corporation |
2h-phthalazin-1-ones and methods for use thereof
|
|
AU2002333193A1
(en)
|
2001-08-15 |
2003-03-03 |
Leo Pharma A/S |
A pharmaceutical composition for dermal application
|
|
WO2003016466A2
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
ANTI-Aβ ANTIBODIES
|
|
JO2311B1
(en)
|
2001-08-29 |
2005-09-12 |
ميرك فروست كندا ليمتد |
Alkyl inhibitors Ariel phosphodiesterase-4
|
|
GB0122031D0
(en)
|
2001-09-12 |
2001-10-31 |
Pfizer Ltd |
Use of pde4 inhibitors in a dry powder inhaler
|
|
WO2003024488A2
(en)
|
2001-09-19 |
2003-03-27 |
Altana Pharma Ag |
Combination of a pde inhibitor and a leukotriene receptor antagonist
|
|
NZ532278A
(en)
|
2001-09-19 |
2006-02-24 |
Altana Pharma Ag |
Combination of a PDE inhibitor and an NSAID
|
|
WO2003035650A1
(en)
|
2001-09-25 |
2003-05-01 |
Takeda Chemical Industries, Ltd. |
Entry inhibitor
|
|
MXPA04003007A
(es)
|
2001-10-02 |
2004-07-15 |
Upjohn Co |
Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades.
|
|
GB0123951D0
(en)
|
2001-10-05 |
2001-11-28 |
Glaxo Group Ltd |
Therapies for treating respiratory diseases
|
|
DE10150517A1
(de)
|
2001-10-12 |
2003-04-17 |
Merck Patent Gmbh |
Verwendung von Phosphodiesterase IV-Inhibitoren
|
|
BR0213660A
(pt)
|
2001-10-16 |
2004-08-24 |
Memory Pharm Corp |
Composto, composição farmacêutica e método para tratar pacientes
|
|
EP2336133A1
(en)
|
2001-10-30 |
2011-06-22 |
Conforma Therapeutics Corporation |
Purine analogs having HSP90-inhibiting activity
|
|
CZ2004516A3
(cs)
|
2001-10-31 |
2004-08-18 |
Merckápatentágmbh |
Inhibitor fosfodiesterázy typu @Ź jeho kombinace s jinými drogami a jeho použití
|
|
WO2003037900A2
(en)
|
2001-11-01 |
2003-05-08 |
Icagen, Inc. |
Pyrazolopyrimidines
|
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
|
MY130622A
(en)
|
2001-11-05 |
2007-07-31 |
Novartis Ag |
Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
|
|
DE60213841T2
(de)
|
2001-11-05 |
2007-02-15 |
Merck Patent Gmbh |
Hydrazono-malonitrile
|
|
US20030092706A1
(en)
|
2001-11-09 |
2003-05-15 |
Johannes Barsig |
Combination
|
|
IS7221A
(is)
|
2001-11-15 |
2004-04-15 |
Memory Pharmaceuticals Corporation |
Hringlaga adenosínmónófosfat fosfódíesterasa 4D7 ísóform og aðferðir til notkunar þeirra
|
|
FR2832711B1
(fr)
|
2001-11-26 |
2004-01-30 |
Warner Lambert Co |
Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
|
|
US20050101000A1
(en)
|
2002-12-11 |
2005-05-12 |
Isis Pharmaceuticals Inc. |
Modulation of phosphodiesterase 4B expression
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
PL377769A1
(pl)
|
2002-10-09 |
2006-02-20 |
Rinat Neuroscience Corp. |
Sposób leczenia choroby Alzheimera z zastosowaniem przeciwciał skierowanych przeciw peptydowi beta amyloidu i ich kompozycje
|
|
AU2003283303A1
(en)
|
2002-11-08 |
2004-06-07 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
|
|
WO2004052315A2
(en)
|
2002-12-11 |
2004-06-24 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2004089471A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
|
|
ES2338656T3
(es)
|
2003-04-11 |
2010-05-11 |
High Point Pharmaceuticals, Llc |
Uso farmaceutico de 1,2,4-triazoles fusionados.
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
US7741341B2
(en)
|
2003-05-19 |
2010-06-22 |
Sanofi-Aventis Deutschland Gmbh |
Benzimidazole-derivatives as factor Xa inhibitors
|
|
WO2004110996A1
(en)
|
2003-06-19 |
2004-12-23 |
Pfizer Products Inc. |
Nk1 antagonist
|
|
US20060148805A1
(en)
|
2003-07-01 |
2006-07-06 |
Meng Hsin Chen |
Opthalmic compositions for treating ocular hypertension
|
|
FR2857966A1
(fr)
|
2003-07-24 |
2005-01-28 |
Aventis Pharma Sa |
Produits aryl-heteroaromatiques, compositions les contenant et utilisation
|
|
US20050020587A1
(en)
|
2003-07-25 |
2005-01-27 |
Pfizer Inc |
Nicotinamide derivatives useful as PDE4 inhibitors
|
|
US20070031416A1
(en)
|
2003-09-09 |
2007-02-08 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
|
GB0322726D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
|
GB0322722D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
|
CA2539752A1
(en)
|
2003-09-29 |
2005-04-07 |
Topigen Pharmaceutique Inc. |
Oligonucleotide compositions and methods for treating disease including inflammatory conditions
|
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
|
WO2005066151A2
(en)
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
WO2005080361A1
(en)
|
2004-02-02 |
2005-09-01 |
Pfizer Products Inc. |
Histamine-3 receptor modulators
|
|
CA2565965A1
(en)
|
2004-05-06 |
2006-07-27 |
Plexxikon, Inc. |
Pde4b inhibitors and uses therefor
|
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
|
MX2007000998A
(es)
|
2004-07-30 |
2007-07-11 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos peptido beta-amiloide y procedimientos que usan los mismos.
|
|
EP1786813A2
(en)
|
2004-09-03 |
2007-05-23 |
Plexxikon, Inc. |
Bicyclic heteroaryl pde4b inhibitors
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
MX2007003329A
(es)
|
2004-09-20 |
2007-06-05 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y biciclicos y su uso como inhibidores de estearoil-coa-desaturasa (scd).
|
|
MX2007003342A
(es)
|
2004-09-21 |
2007-06-05 |
Synta Pharmaceutical Corp |
Compuestos para inflamacion y usos relacionados con trastornos inmunitarios.
|
|
FR2877015B1
(fr)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
Revetement nanostructure et procede de revetement.
|
|
DE102004054634A1
(de)
*
|
2004-11-12 |
2006-05-18 |
Schwarz Pharma Ag |
Azaindolcarboxamide
|
|
EP1827493A4
(en)
|
2004-12-22 |
2009-09-30 |
Univ St Louis |
USE OF ANTI-ABETA ANTIBODIES FOR THE TREATMENT OF BRAIN TRAUMA
|
|
US20100130737A1
(en)
|
2005-02-18 |
2010-05-27 |
Takeda Pharmaceutical Company Limited |
Regulating Agent of GPR34 Receptor Function
|
|
GB0503955D0
(en)
|
2005-02-25 |
2005-04-06 |
Glaxo Group Ltd |
Novel compounds
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
EP1881985B1
(en)
|
2005-05-12 |
2010-12-29 |
Pfizer, Inc. |
Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide
|
|
WO2006126081A2
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
|
|
CA2608672A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
|
DE602006018301D1
(de)
|
2005-06-22 |
2010-12-30 |
Pfizer Prod Inc |
Histamin-3-rezeptorantagonisten
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
CA2624625A1
(en)
|
2005-11-04 |
2007-05-10 |
Pfizer Limited |
Tetrahydronaphthyridine derivative
|
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
|
JP2009539762A
(ja)
|
2006-03-13 |
2009-11-19 |
ファイザー・プロダクツ・インク |
Ｈ３受容体のテトラリン拮抗薬
|
|
GB0605462D0
(en)
|
2006-03-17 |
2006-04-26 |
Glaxo Group Ltd |
Novel compounds
|
|
CN101454320B
(zh)
|
2006-04-21 |
2012-12-19 |
辉瑞产品公司 |
吡啶并[3，4-b]吡嗪酮
|
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
|
US20080090834A1
(en)
|
2006-07-06 |
2008-04-17 |
Pfizer Inc |
Selective azole pde10a inhibitor compounds
|
|
KR20090109527A
(ko)
|
2006-07-07 |
2009-10-20 |
칼립시스, 인코포레이티드 |
Ｐｄｅ４의 바이사이클릭 헤테로아릴 억제제
|
|
US8138205B2
(en)
|
2006-07-07 |
2012-03-20 |
Kalypsys, Inc. |
Heteroarylalkoxy-substituted quinolone inhibitors of PDE4
|
|
RU2450004C2
(ru)
|
2006-08-04 |
2012-05-10 |
Мерц Фарма Гмбх Унд Ко. Кгаа |
Замещенные пиразолопиримидины, способ их получения и их применение в качестве лекарственного средства
|
|
EP1900739A1
(en)
|
2006-08-30 |
2008-03-19 |
Cellzome Ag |
Diazolodiazine derivatives as kinase inhibitors
|
|
WO2008033739A2
(en)
*
|
2006-09-12 |
2008-03-20 |
Neurogen Corporation |
Benzimidazole carboxamide derivatives
|
|
WO2008045664A2
(en)
|
2006-10-06 |
2008-04-17 |
Kalypsys, Inc. |
Heterocyclic pde4 inhibitors as antiinflammatory agents
|
|
WO2008045663A2
(en)
|
2006-10-06 |
2008-04-17 |
Kalypsys, Inc. |
Aryl-substituted heterocyclic pde4 inhibitors as antiinflammatory agents
|
|
US20080102475A1
(en)
|
2006-10-13 |
2008-05-01 |
Zhengyan Kan |
Alternatively spliced isoform of phosphodiesterase 4B (PDE4B)
|
|
CL2007002994A1
(es)
|
2006-10-19 |
2008-02-08 |
Wyeth Corp |
Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
|
|
WO2008056176A1
(en)
|
2006-11-10 |
2008-05-15 |
Scottish Biomedical Limited |
Pyrazolopyrimidines as phosphodiesterase inhibitors
|
|
JP4585610B2
(ja)
|
2007-01-22 |
2010-11-24 |
ファイザー・プロダクツ・インク |
治療用化合物のトシル酸塩およびその医薬組成物
|
|
BRPI0812594A2
(pt)
|
2007-08-10 |
2015-06-23 |
Lundbeck & Co As H |
Composto ou sal ou hidrato do mesmo, composição farmacêutica, métodos para modulação da atividade de um receptor p2x7, para tratamento de uma condição responsiva á modulação do receptor p2x7 em um paciente, para inibição de morte de células gangliônicas retinais em um paciente, para determinação da presença ou ausência de receptor p2x7 em uma amostra, preparação farmacêutica acondicionada, e, uso de um composto ou sal ou hidrato do mesmo.
|
|
US20090176778A1
(en)
|
2007-08-10 |
2009-07-09 |
Franz Ulrich Schmitz |
Certain nitrogen containing bicyclic chemical entities for treating viral infections
|
|
EP2085398A1
(en)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, a process for their preparation and their use as medicine
|
|
WO2009108551A2
(en)
|
2008-02-25 |
2009-09-03 |
H. Lundbeck A/S |
Heteroaryl amide analogues
|
|
GB2461702A
(en)
|
2008-07-08 |
2010-01-13 |
Dyson Technology Ltd |
Hand drying apparatus
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
CN102223798A
(zh)
|
2008-09-24 |
2011-10-19 |
巴斯夫欧洲公司 |
用于防治无脊椎动物害虫的吡唑化合物
|
|
WO2010059836A1
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Substituted aza-bridged bicyclics for cardiovascular and cns disease
|
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
|
EP2408446B1
(en)
|
2009-03-20 |
2019-09-11 |
HG&H Pharmaceuticals (Pty) Limited |
Use of pharmaceutical compositions containing mesembrenone
|
|
JP5641664B2
(ja)
|
2009-10-30 |
2014-12-17 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ |
イミダゾ［１，２−ｂ］ピリダジン誘導体およびＰＤＥ１０阻害剤としてのそれらの使用
|
|
EP2504340A1
(en)
|
2009-11-25 |
2012-10-03 |
Merz Pharma GmbH & Co. KGaA |
Crystalline forms of substituted pyrazolopyrimidines
|
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
|
CA2792339A1
(en)
|
2010-03-23 |
2011-09-29 |
High Point Pharmaceuticals, Llc |
Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
|
|
UY33373A
(es)
|
2010-05-10 |
2011-12-30 |
Gilead Sciences Inc |
?Compuestos de pirazolopiridina bifuncionales, su uso en terapia y composiciones que los comprenden?.
|
|
JP5807058B2
(ja)
|
2010-05-10 |
2015-11-10 |
ギリアード サイエンシーズ， インコーポレイテッド |
二機能キノリン誘導体
|
|
US8609669B2
(en)
|
2010-11-16 |
2013-12-17 |
Abbvie Inc. |
Potassium channel modulators
|
|
US9096605B2
(en)
|
2011-08-24 |
2015-08-04 |
Glaxosmithkline Llc |
Pyrazolopyrimidine derivatives as PI3 kinase inhibitors
|
|
CA2900302C
(en)
|
2013-02-19 |
2018-07-03 |
Pfizer Inc. |
Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
|
|
US9193736B2
(en)
|
2013-06-11 |
2015-11-24 |
Janssen Pharmaceutica, Nv |
PDE 10a inhibitors for the treatment of type II diabetes
|
|
GB201321734D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
CN111772834B
(zh)
|
2014-03-21 |
2022-07-15 |
阿莱恩技术有限公司 |
具有弹性体的分段的正畸矫正器
|
|
WO2016012896A1
(en)
|
2014-07-24 |
2016-01-28 |
Pfizer Inc. |
Pyrazolopyrimidine compounds
|
|
CR20170035A
(es)
|
2014-08-06 |
2017-04-28 |
Pfizer |
Compuestos de imidazopiridazina
|